Delaunay, S., F. Rapino, L. Tharun, Z. Zhou, L. Heukamp, M. Termathe, K. Shostak, I. Klevernic, A. Florin, H. Desmecht, C. J. Desmet, L. Nguyen, S. A. Leidel, A. E. Willis, R. Büttner, A. Chariot and P. Close: Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer. In: The Journal of Experimental Medicine 213, 11, 2503-2523 (2016).
url: http://www.jem.org/lookup/doi/10.1084/jem.20160397 %> file://localhost/Users/falkon/Documents/Papers2/Articles/2016/Delaunay/Delaunay_Close_J.%20Exp.%20Med._2016-1.pdf %G English
Scheffler, M., T. Zander, L. Nogova, C. Kobe, D. Kahraman, F. Dietlein, I. Papachristou, L. Heukamp, R. Büttner, R. Boellaard, A. A. Lammertsma, S. Querings, E. Stoelben, W. Engel-Riedel, B. Neumaier and J. Wolf: Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with Erlotinib. In: PLoS ONE 8, 1, Seq. No.: e53081 (2013).
doi: 10.1371/journal.pone.0053081
Gruber, S., B. Straub, P. J. Ackermann, C. M. Wunderlich, J. Mauer, J. M. Seeger, H. Büning, L. Heukamp, H. Kashkar, P. Schirmacher, J. C. Brüning and F. T. Wunderlich: Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling. In: Cell Reports 4, 4, 669-680 (2013).
doi: 10.1016/j.celrep.2013.07.023
Gruber, S., B. Straub, P. J. Ackermann, C. M. Wunderlich, J. Mauer, J. M. Seeger, H. Büning, L. Heukamp, H. Kashkar, P. Schirmacher, J. C. Brüning and F. T. Wunderlich: Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling. In: Cell Reports 4, 4, 669-680 (2013).
doi: 10.1016/j.celrep.2013.07.023
Höpker, K., H. Hagmann, S. Khurshid, S. Chen, P. Hasskamp, T. Seeger-Nukpezah, K. Schilberg, L. Heukamp, T. Lamkemeyer, M. L. Sos, R. K. Thomas, D. Lowery, F. Roels, M. Fischer, M. C. Liebau, U. Resch, T. Kisner, F. Röther, M. P. Bartram, R. U. Müller, F. Fabretti, P. Kurschat, B. Schumacher, M. Gaestel, R. H. Medema, M. B. Yaffe, B. Schermer, H. C. Reinhard and T. Benzing: AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. In: EMBO Journal 31, 20, 3961-3975 (2012).
doi: 10.1038/emboj.2012.236
Sos, M. L., F. Dietlein, M. Peifer, J. Schöttle, H. Balke-Want, C. Müller, M. Koker, A. Richters, S. Heynck, F. Malchers, J. M. Heuckmann, D. Seidel, P. A. Eyers, R. T. Ullrich, A. P. Antonchik, V. V. Vintonyak, P. M. Schneider, T. Ninomiya, H. H. Waldmann, R. Büttner, D. Rauh, L. Heukamp and R. K. Thomas: A framework for identification of actionable cancer genome dependencies in small cell lung cancer. In: Proceedings of the National Academy of Sciences of the United States of America 109, 42, 17034-17039 (2012).
doi: 10.1073/pnas.1207310109
Zander, T., M. Scheffler, L. Nogova, C. Kobe, W. Engel-Riedel, M. Hellmich, I. Papachristou, K. Toepelt, A. Draube, L. Heukamp, R. Buettner, Y. D. Ko, R. T. Ullrich, E. Smit, R. Boellaard, A. A. Lammertsma, M. Hallek, A. H. Jacobs, A. Schlesinger, K. Schulte, S. Querings, E. Stoelben, B. Neumaier, R. K. Thomas, M. Dietlein and J. Wolf: Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. In: Journal of Clinical Oncology 29, 13, 1701-1708 (2011).
doi: 10.1200/JCO.2010.32.4939
Zander, T., M. Scheffler, L. Nogova, C. Kobe, W. Engel-Riedel, M. Hellmich, I. Papachristou, K. Toepelt, A. Draube, L. Heukamp, R. Buettner, Y. D. Ko, R. T. Ullrich, E. Smit, R. Boellaard, A. A. Lammertsma, M. Hallek, A. H. Jacobs, A. Schlesinger, K. Schulte, S. Querings, E. Stoelben, B. Neumaier, R. K. Thomas, M. Dietlein and J. Wolf: Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. In: Journal of Clinical Oncology 29, 13, 1701-1708 (2011).
doi: 10.1200/JCO.2010.32.4939
Zander, T., M. Scheffler, L. Nogova, C. Kobe, W. Engel-Riedel, M. Hellmich, I. Papachristou, K. Toepelt, A. Draube, L. Heukamp, R. Buettner, Y. D. Ko, R. T. Ullrich, E. Smit, R. Boellaard, A. A. Lammertsma, M. Hallek, A. H. Jacobs, A. Schlesinger, K. Schulte, S. Querings, E. Stoelben, B. Neumaier, R. K. Thomas, M. Dietlein and J. Wolf: Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. In: Journal of Clinical Oncology 29, 13, 1701-1708 (2011).
doi: 10.1200/JCO.2010.32.4939
Zander, T., M. Scheffler, L. Nogova, C. Kobe, W. Engel-Riedel, M. Hellmich, I. Papachristou, K. Toepelt, A. Draube, L. Heukamp, R. Buettner, Y. D. Ko, R. T. Ullrich, E. Smit, R. Boellaard, A. A. Lammertsma, M. Hallek, A. H. Jacobs, A. Schlesinger, K. Schulte, S. Querings, E. Stoelben, B. Neumaier, R. K. Thomas, M. Dietlein and J. Wolf: Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. In: Journal of Clinical Oncology 29, 13, 1701-1708 (2011).
doi: 10.1200/JCO.2010.32.4939
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.